High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan

2020 ◽  
Vol 25 (7) ◽  
pp. 1327-1333
Author(s):  
S. Yazaki ◽  
T. Yamauchi ◽  
T. Higashi
2016 ◽  
Vol 21 (6) ◽  
pp. 1162-1166 ◽  
Author(s):  
Masafumi Ikeda ◽  
Hiroki Yamamoto ◽  
Makiko Kaneko ◽  
Hiroshi Oshima ◽  
Hideaki Takahashi ◽  
...  

Cancer ◽  
2016 ◽  
Vol 123 (4) ◽  
pp. 650-656 ◽  
Author(s):  
Kevin Junus ◽  
Maria Aguilar ◽  
Priya Patel ◽  
David Irwin ◽  
Stephen Yee ◽  
...  

2020 ◽  
Vol 16 (1) ◽  
pp. 157-161
Author(s):  
Ewa Kalinka ◽  
Joanna Drozd-Sokołowska ◽  
Anna Waszczuk-Gajda ◽  
Joanna Barankiewicz ◽  
Elżbieta Zalewska ◽  
...  

2003 ◽  
Vol 10 (4) ◽  
pp. 331-334 ◽  
Author(s):  
D. T.-Y. Lau ◽  
H. Ma ◽  
S. M. Lemon ◽  
E. Doo ◽  
M. G. Ghany ◽  
...  

Author(s):  
Elizabeth Hastie ◽  
Darcy Wooten

Abstract This survey study evaluates how clinicians approach HBV vaccination and monitoring in patients living with HIV. Providers have clinical practices that vary greatly from one another and from current guidelines especially for patients who do not seroconvert after initial HBV vaccination and for patients with isolated hepatitis B core antibody.


Sign in / Sign up

Export Citation Format

Share Document